A new cost analysis finds that matching relapsed lymphoma treatment to a personalized drug-response test was associated with longer disease control and a lower estimated daily treatment cost in dogs.
|Articles|June 7, 2023
Morris Animal Foundation accepting canine cancer research proposals
Author(s)dvm360 Staff
Encourages individuals from historically marginalized groups to apply to diversify animal health research community
Advertisement
Morris Animal Foundation is now accepting proposals for canine cancer research with a particular interest in studies in the areas of genetic epidemiology, genetic and epigenetic changes predictive of cancer risk, development of diagnostic and therapeutic biomarkers, and tumor genomic profiling.1
According to an organizational release,1 the foundation is looking for projects that maximize specimens and information from the Golden Retriever Lifetime Study,2 but also welcomes submissions using other data.
Advertisement
“The Golden Retriever Lifetime Study provides a unique opportunity to understand the origins of canine cancer,” said Kathy Tietje, PhD, MBA,chief program officer at Morris Animal Foundation, in the release. “We encourage the scientific community to include Study resources in their research proposals.”
Additionally, Morris Animal Foundation encourages fellowship applications from those from historically marginalized groups. These Minority Fellowships are being funded by Sally R. McIntosh through the Donor-Inspired Study program. McIntosh aims to offer fellowship funding to support applicants from historically marginalized groups interested in studying canine health to make "a tiny dent" in diversifying the animal health research community.1
Interested researchers can find more information on Morris Animal Foundation’s Grants page. Proposals are due August 16, 2023.
References
- Canine cancer focus of latest Morris Animal Foundation call for research proposals. News release. Morris Animal Foundation. June 7, 2023. Accessed June 7, 2023.
- Golden retriever lifetime study. Morris Animal Foundation. Accessed June 7, 2023. https://www.morrisanimalfoundation.org/golden-retriever-lifetime-study
Advertisement
Related to this article
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.
Preclinical testing at The Ohio State University found Telomir-Zn inhibited the growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in vivo study in dogs with naturally occurring tumors.
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.
Fifteen second-year veterinary students will each receive $20,000, along with mentorship and leadership training that continues after graduation.
Alyssa Mages, BS, CVT, FVTE, shares guidance on assessing emergency patients, communicating with distressed clients, and establishing a team-based triage process.
Here are this week's headlines.
Pyometra is a common and serious illness in adult intact dogs and cats. Because a patient experiencing pyometra may deteriorate rapidly, this condition requires emergency intervention.
Advertisement
Advertisement
Trending on dvm360
1
AAVMC and Chewy Health open nominations for 2027 veterinary student leadership scholarships
2
Saline injection lot recalled after potassium chloride bag found in mislabeled wrap
3
Pet Poison Helpline reports rise in Apoquel calls
4
Fungus-contaminated wound product linked to infections in nearly 100 horses, at least 20 euthanized
5